Literature DB >> 226639

Preparation and properties of soluble, immunoreactive apoLDL.

L Socorro, G Camejo.   

Abstract

Immunoreactive apo-low density lipoprotein (LDL), soluble in mildly alkaline buffers of low ionic strength, was prepared by attaching LDL to a DEAE-Sepharose column and eluting the lipids with a 0--2% (w/v) gradient of nonionic detergents. Brij-36T, Nonidet P-40, and Triton X-100 gave similar results. After washing the detergent from the column, the bound apoLDL was eluted with 1 M NaCl, pH 7.4, with recoveries up to 85%. This apoLDL could be dialyzed extensively against low ionic strength solutions, and remained soluble as long as the pH was above 7. Spectrophotometric analysis showed that less than 0.1% %w/v) of cholesterol or phospholipids and less than 1% (w/v) of detergent remained associated with the protein. The apoLDL cross-reacted with LDL against antisera prepared vs. intact LDL. Pore-gradient polyacrylamide gel electrophoresis, with SDS and urea, showed that this preparation was less aggregated than organic solvent extracted apolLDL and appeared to be made of oligomers of two monomeric subunits, one with molecular weight around 22,700 and a smaller one of approximately 8000. Isoelectric focusing showed that there also was charge heterogeneity in the soluble apoLDL.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 226639

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

1.  Protein sequencing by tandem mass spectrometry.

Authors:  D F Hunt; J R Yates; J Shabanowitz; S Winston; C R Hauer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

2.  Detection of unique antigenic determinants on human plasma low density lipoprotein and on delipidated apolipoprotein B.

Authors:  T S Watt; R M Watt
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

3.  Apolipoprotein C-III-1 activates lysosomal sphingomyelinase in vitro.

Authors:  A J Alpert; A L Beaudet
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

4.  Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons.

Authors:  J P Kane; D A Hardman; H E Paulus
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

5.  Human apolipoprotein B: identification of cDNA clones and characterization of mRNA.

Authors:  M Mehrabian; V N Schumaker; G C Fareed; R West; D F Johnson; T Kirchgessner; H C Lin; X B Wang; Y H Ma; E Mendiaz
Journal:  Nucleic Acids Res       Date:  1985-10-11       Impact factor: 16.971

6.  Cloning and expression of apolipoprotein B, the major protein of low and very low density lipoproteins.

Authors:  A J Lusis; R West; M Mehrabian; M A Reuben; R C LeBoeuf; J S Kaptein; D F Johnson; V N Schumaker; M P Yuhasz; M C Schotz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

7.  A partial cDNA clone for human apolipoprotein B.

Authors:  S S Deeb; A G Motulsky; J J Albers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

8.  Determination of the molecular mass of apolipoprotein B-100. A chemical approach.

Authors:  C Y Yang; F S Lee; L Chan; D A Sparrow; J T Sparrow; A M Gotto
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

9.  Comparison of apoprotein B of low density lipoproteins of human interstitial fluid and plasma.

Authors:  J L Hong; J Pflug; D Reichl
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

10.  Dietary cholesterol does not affect the synthesis of apolipoproteins B and E by rat hepatocytes.

Authors:  R A Davis; M Malone-McNeal
Journal:  Biochem J       Date:  1985-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.